Cytel Wins Prestigious Scrip Award for Best Contract Research Organization - Specialist Providers

Award recognizes Cytel as an expert provider of analytical solutions for clinical development.

Cambridge, MA, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Cytel Inc., a global provider of analytical clinical research services and software to the pharmaceutical, biotechnology, and medical device industries, announced today that it has been awarded the prestigious 2018 Scrip Award for Best Contract Research Organization (CRO) – Specialist Providers. The accolade was presented at an awards ceremony in London on 28th November 2018.

The Scrip Awards acknowledge the pharmaceutical and biotechnology industry’s highest achievers across the value chain. The Best Contract Research Organization – Specialist Providers category highlights the critical role that CROs play in clinical development and particularly commends quality of service and strength of customer relationships.  Cytel was selected as the winner by an independent panel of senior industry experts based on its performance across the following key criteria:

      • Capabilities and strengths
      • Delivery of results that exceed sponsor expectations
      • Innovations brought to sponsors
      • Improvements made in the quality of data, timelines, and transparency
      • Measures to streamline data collection and reporting

 “We are honored to be recognized as the industry’s best specialist CRO by Scrip. More than anything, this award belongs to our exceptionally talented staff who work tirelessly applying expertise in statistical science to deliver critical insights that help sponsors bring new medicines to patients, faster,” said Irving Dark, Senior Vice President of Clinical Research Services at Cytel.  “A commitment to creating tailored partnerships with our customers, and consistently exceeding their expectations is a fundamental value for our highly skilled global team. We are thrilled that the Scrip panel noted how our innovation and operational excellence in trial design and analytics make a real difference to our customers’ success and the drug development effort as a whole.  As we look to the future, we believe Cytel is uniquely capable of unlocking even greater insights from the rapidly expanding data sources being used across all phases of clinical development.”

The award follows Cytel’s recognition at Informa’s CARE Awards in 2017 for Most Innovative Trial Design.  At the 2018 Scrip Awards, Cytel was also shortlisted as a finalist in the Best Technological Development in Clinical Trials – Clinical Sponsor-focused category for its first to market go/no-go decision-making software OK GO.

Connect with Cytel

Read our blog

Follow us on Twitter   @cytel

Engage with us on LinkedIn 

About Cytel

As a pioneer in evidence generation, with deep expertise in advanced analytical solutions, Cytel is uniquely equipped to unlock the value from increasingly complex data. Life sciences companies count on Cytel to deliver exceptional insight, minimize trial risk and accelerate the development of promising new medicines that improve human life. Cytel provides data-focused clinical research services and software solutions for the design and analysis of clinical trials, including industry standards East®, StatXact®, and LogXact®. With operations across North America, Europe, and India, Cytel employs 900 professionals, with strong talent in biostatistics, programming, data science, and data management. For more information about Cytel, visit


Scrip Awards Winner 2018
Best Contract Research Organization- Specialist Providers

Contact Data